GlassScriptPhysician profile
Rajen D Desai
NPI 1679551386
$15,816.44
in general payments reported to CMS, 2019-2025
47 companies · $1,305 in 2025
The $1,305 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,468 · 2020: $1,309 · 2021: $1,440 · 2022: $1,502 · 2023: $2,133 · 2024: $1,658 · 2025: $1,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,096.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $4,317.78 | 2019-2025 | Impella |
| Biotronik INC. | $1,889.31 | 2019 | |
| Ekos Corporation | $1,588.28 | 2019 | |
| Novartis Pharmaceuticals Corporation | $1,394.48 | 2019-2025 | |
| Canon Medical Systems USA, INC. | $947.78 | 2019 | |
| Boston Scientific Corporation | $839.20 | 2019-2025 | Mylux Patient Kit With Mobile Device, Varithena Administration Pack, General - Ep |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $525.75 | 2019-2025 | Lifevest |
| Tactile Systems Technology INC | $449.08 | 2019-2021 | |
| Philips North America LLC | $290.80 | 2019 | |
| Pfizer INC. | $267.93 | 2022-2025 | |
| Medtronic Vascular, INC. | $258.69 | 2019 | |
| Acutus Medical, INC. | $195.67 | 2021 | |
| Edwards Lifesciences Corporation | $195.13 | 2024-2025 | Sapien 3 Ultra Resilia, Pascal |
| Janssen Pharmaceuticals, INC | $192.83 | 2019-2024 | Xarelto |
| Medtronic, INC. | $189.27 | 2021-2023 | Onyx Frontier |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $186.59 | 2020-2023 | Mitraclip |
| Zoll Respicardia, INC. | $168.28 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $166.73 | 2019-2025 | Eliquis |
| Chiesi USA, INC. | $152.42 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $141.22 | 2022-2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $116.75 | 2024-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $113.10 | 2021-2025 | Verquvo |
| Impulse Dynamics (USA) INC. | $110.57 | 2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $99.26 | 2019-2025 | Farxiga |
| Bard Peripheral Vascular, INC. | $92.85 | 2020 | |
| Recor Medical INC | $82.33 | 2024 | Paradise Renal Denervation System |
| Bardy Diagnostics, INC. | $80.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $75.88 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.05 | 2022-2025 | |
| Amgen INC. | $68.59 | 2019-2024 | Repatha |
| Novo Nordisk INC | $66.70 | 2022-2025 | Ozempic, Wegovy |
| Welch Allyn | $66.07 | 2021 | |
| Ocular Therapeutix, INC. | $50.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.27 | 2021-2025 | Jardiance |
| Inari Medical, INC. | $45.74 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lexicon Pharmaceuticals, INC. | $38.27 | 2024 | |
| Johnson & Johnson Surgical Vision, INC. | $34.32 | 2022 | |
| Biosense Webster, INC. | $27.50 | 2024 | Carto 3 |
| Cvrx, INC. | $23.07 | 2023 | Barostim Neo System |
| Daiichi Sankyo INC. | $22.53 | 2023 | Injectafer |
| Terumo Medical Corporation | $21.67 | 2024 | Azur Cx Detachable |
| Kowa Pharmaceuticals America, INC. | $20.00 | 2021 | |
| Baxter Healthcare | $19.52 | 2024 | Perclot |
| Nalu Medical, INC. | $17.07 | 2024 | Nalu Neurostimulation System |
| Covidien LP | $15.47 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.07 | 2023 | Amvuttra |
| Sun Pharmaceutical Industries INC. | $14.57 | 2023 | Cequa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajen Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.